Article Information
History
- April 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Enrique M. Garcia-Rivera1,
- Jiho Park1,
- Aakash Desai2,
- Romain Boidot3,
- Sandy Chevrier3,
- Caroline Truntzer4,
- François Ghiringhelli5,
- Mitesh Borad6,7 and
- Aaron S. Mansfield2,7,*
- 1nference, Cambridge, Massachusetts, USA
- 2Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA
- 3Unit of Molecular Biology, Georges-François Leclerc cancer center, Dijon, France
- 4Genetic and Immunology Medical Institute, Dijon, France
- 5University of Burgundy Franche-Comté, France
- 6Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA
- 7Co-Directors of Precision Cancer Therapeutics within the Center of Individualized Medicine, Mayo Clinic, USA
- ↵*Corresponding author; email: mansfield.aaron{at}mayo.edu